Miraki’s Velis on investing in lab technology and reserving for today’s larger rounds

VCJ Venture Top of Mind
Velis: There are more companies out there under valued and struggling in medtech and in need of capital than there are receiving those unicorn type valuations

To view this content you must sign in:

Not yet registered? Join today to access PE Hub industry insights and updates.